Physician profile
Melanie Chatterji
NPI 1053371492
$1,628.90
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,393 · 2020: $215 · 2021: $21.15.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $231.08 | 2019-2020 | |
| Janssen Biotech, INC. | $183.35 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $151.84 | 2019-2020 | |
| Abbvie INC. | $127.95 | 2019-2021 | |
| Ucb, INC. | $101.56 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $93.57 | 2019 | |
| Pfizer INC. | $93.13 | 2019-2020 | |
| Glaxosmithkline, LLC. | $81.16 | 2019-2020 | |
| Hikma Pharmaceuticals USA | $79.07 | 2019 | |
| Celgene Corporation | $72.71 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $61.11 | 2019 | |
| Radius Health, INC. | $59.94 | 2019 | |
| Daiichi Sankyo INC. | $44.76 | 2019 | |
| Merck Sharp & Dohme LLC | $37.64 | 2019 | |
| Lilly USA, LLC | $34.12 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $33.43 | 2019 | |
| Mallinckrodt Enterprises LLC | $31.15 | 2019 | |
| Pacira Therapeutics, INC. | $28.28 | 2019 | |
| Antares Pharma, INC. | $19.43 | 2019 | |
| Sanofi-Aventis U.S. LLC | $19.11 | 2019 | |
| Horizon Therapeutics Plc | $18.31 | 2019 | |
| Genentech USA, INC. | $14.57 | 2019 | |
| Medexus Pharma, INC. | $11.63 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melanie Chatterji listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.